| Literature DB >> 27376578 |
Carmen Adriaens1,2, Laura Standaert1,2, Jasmine Barra1,2, Mathilde Latil3, Annelien Verfaillie4, Peter Kalev5,6, Bram Boeckx7,8, Paul W G Wijnhoven9, Enrico Radaelli10, William Vermi11,12, Eleonora Leucci1,2, Gaëlle Lapouge3, Benjamin Beck3, Joost van den Oord13, Shinichi Nakagawa14,15, Tetsuro Hirose16, Anna A Sablina5,6, Diether Lambrechts7,8, Stein Aerts4, Cédric Blanpain3,17, Jean-Christophe Marine1,2.
Abstract
In a search for mediators of the p53 tumor suppressor pathway, which induces pleiotropic and often antagonistic cellular responses, we identified the long noncoding RNA (lncRNA) NEAT1. NEAT1 is an essential architectural component of paraspeckle nuclear bodies, whose pathophysiological relevance remains unclear. Activation of p53, pharmacologically or by oncogene-induced replication stress, stimulated the formation of paraspeckles in mouse and human cells. Silencing Neat1 expression in mice, which prevents paraspeckle formation, sensitized preneoplastic cells to DNA-damage-induced cell death and impaired skin tumorigenesis. We provide mechanistic evidence that NEAT1 promotes ATR signaling in response to replication stress and is thereby engaged in a negative feedback loop that attenuates oncogene-dependent activation of p53. NEAT1 targeting in established human cancer cell lines induced synthetic lethality with genotoxic chemotherapeutics, including PARP inhibitors, and nongenotoxic activation of p53. This study establishes a key genetic link between NEAT1 paraspeckles, p53 biology and tumorigenesis and identifies NEAT1 as a promising target to enhance sensitivity of cancer cells to both chemotherapy and p53 reactivation therapy.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27376578 DOI: 10.1038/nm.4135
Source DB: PubMed Journal: Nat Med ISSN: 1078-8956 Impact factor: 53.440